Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis
Hematol., Transfus. Cell Ther. (Impr.)
; 45(2): 275-277, Apr.-June 2023.
Article
in English
| LILACS
| ID: biblio-1448356
Responsible library:
BR408.1
Localization: BR408.1
Full text:
Available
Collection:
International databases
Database:
LILACS
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Hematopoietic Stem Cell Transplantation
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Hematol., Transfus. Cell Ther. (Impr.)
Journal subject:
Hematologia
/
TransfusÆo de Sangue
Year:
2023
Document type:
Article
Affiliation country:
Turkey
Institution/Affiliation country:
Istanbul University-Cerrahpaşa/TR